GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Tariff Resilience Score

Hamlet BioPharma AB publ (XSAT:HAMLET B) Tariff Resilience Score : 0/10 (As of Jul. 13, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Tariff Resilience Score?

Hamlet BioPharma AB publ has the Tariff Resilience Score of 0, which implies that the company might have .

Hamlet BioPharma AB publ has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Hamlet BioPharma AB publ might have .


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Hamlet BioPharma AB publ Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines